Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BEAT Relative to the S&P 500

BEAT Relative to the Sector

Seasonal Chart Analysis

Analysis of the HeartBeam Inc. (NASD:BEAT) seasonal charts above shows that a Buy Date of September 13 and a Sell Date of December 23 has resulted in a geometric average return of 56.72% above the benchmark rate of the S&P 500 Total Return Index over the past 3 years. This seasonal timeframe has shown positive results compared to the benchmark in 3 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 3 years by an average of 73.36% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 3 years of data is available for shares of BEAT, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (“ECG”) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography (“VECG”) technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration (“FDA”) clearance for its initial telehealth products.

To download BEAT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BEAT